InspireMD annual operating margin
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
InspireMD's operating margin was −552.56% for fiscal 2025.
View full InspireMD company overview| Fiscal year | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | −552.56% | −74.56 pp |
| 2024 | 2024-12-31 | −478.00% | −137.26 pp |
| 2023 | 2023-12-31 | −340.74% | +21.14 pp |
| 2022 | 2022-12-31 | −361.88% | −34.50 pp |
| 2021 | 2021-12-31 | −327.39% | +90.32 pp |
| 2020 | 2020-12-31 | −417.71% | −153.91 pp |
| 2019 | 2019-12-31 | −263.80% | −52.44 pp |
| 2018 | 2018-12-31 | −211.36% | +86.79 pp |
| 2017 | 2017-12-31 | −298.15% | +105.65 pp |
| 2016 | 2016-12-31 | −403.80% | +223.25 pp |
| 2015 | 2015-12-31 | −627.06% | +213.89 pp |
| 2014 | 2014-12-31 | −840.95% | −531.63 pp |
| 2013 | 2013-06-30 | −309.32% | +18.69 pp |
| 2012 | 2012-06-30 | −328.01% | −99.34 pp |
| 2011 | 2011-12-31 | −228.66% | −163.62 pp |
| 2010 | 2010-12-31 | −65.04% | +14.61 pp |
| 2009 | 2009-12-31 | −79.65% | — |
| Fiscal quarter | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| Q2 2026 | 2026-06-30 | −815.64% | −83.41 pp |
| Q1 2026 | 2026-03-31 | −411.36% | +338.15 pp |
| Q4 2025 | 2025-12-31 | −383.74% | +96.86 pp |
| Q3 2025 | 2025-09-30 | −517.28% | −49.77 pp |
| Q2 2025 | 2025-06-30 | −732.23% | −257.24 pp |
| Q1 2025 | 2025-03-31 | −749.51% | −258.84 pp |
| Q4 2024 | 2024-12-31 | −480.61% | −150.79 pp |
| Q3 2024 | 2024-09-30 | −467.51% | −105.11 pp |
| Q2 2024 | 2024-06-30 | −474.99% | −152.67 pp |
| Q1 2024 | 2024-03-31 | −490.67% | −137.08 pp |
| Q4 2023 | 2023-12-31 | −329.81% | +151.28 pp |
| Q3 2023 | 2023-09-30 | −362.40% | −40.25 pp |
| Q2 2023 | 2023-06-30 | −322.32% | −16.57 pp |
| Q1 2023 | 2023-03-31 | −353.59% | +25.61 pp |
| Q4 2022 | 2022-12-31 | −481.09% | −196.24 pp |
| Q3 2022 | 2022-09-30 | −322.15% | +54.22 pp |
| Q2 2022 | 2022-06-30 | −305.75% | +25.66 pp |
| Q1 2022 | 2022-03-31 | −379.21% | −49.78 pp |
| Q4 2021 | 2021-12-31 | −284.86% | +2068.31 pp |
| Q3 2021 | 2021-09-30 | −376.38% | −152.40 pp |
| Q2 2021 | 2021-06-30 | −331.41% | +450.06 pp |
| Q1 2021 | 2021-03-31 | −329.42% | −133.97 pp |
| Q4 2020 | 2020-12-31 | −2,353.16% | −2105.78 pp |
| Q3 2020 | 2020-09-30 | −223.98% | −11.31 pp |
| Q2 2020 | 2020-06-30 | −781.47% | −620.24 pp |
| Q1 2020 | 2020-03-31 | −195.45% | +558.76 pp |
| Q4 2019 | 2019-12-31 | −247.38% | +20.99 pp |
| Q3 2019 | 2019-09-30 | −212.67% | +44.67 pp |
| Q2 2019 | 2019-06-30 | −161.23% | −14.37 pp |
| Q1 2019 | 2019-03-31 | −754.22% | −560.27 pp |
| Q4 2018 | 2018-12-31 | −268.37% | −94.63 pp |
| Q3 2018 | 2018-09-30 | −257.35% | +33.04 pp |
| Q2 2018 | 2018-06-30 | −146.86% | +211.58 pp |
| Q1 2018 | 2018-03-31 | −193.94% | +228.55 pp |
| Q4 2017 | 2017-12-31 | −173.74% | +476.57 pp |
| Q3 2017 | 2017-09-30 | −290.39% | +84.45 pp |
| Q2 2017 | 2017-06-30 | −358.44% | −31.40 pp |
| Q1 2017 | 2017-03-31 | −422.50% | −61.93 pp |
| Q4 2016 | 2016-12-31 | −650.31% | −144.30 pp |
| Q3 2016 | 2016-09-30 | −374.84% | +164.88 pp |
| Q2 2016 | 2016-06-30 | −327.04% | +194.57 pp |
| Q1 2016 | 2016-03-31 | −360.57% | +664.59 pp |
| Q4 2015 | 2015-12-31 | −506.01% | +5.14 pp |
| Q3 2015 | 2015-09-30 | −539.72% | +1834.28 pp |
| Q2 2015 | 2015-06-30 | −521.61% | +3227.10 pp |
| Q1 2015 | 2015-03-31 | −1,025.16% | −651.68 pp |
| Q4 2014 | 2014-12-31 | −511.15% | −260.83 pp |
| Q3 2014 | 2014-09-30 | −2,373.99% | −2092.99 pp |
| Q2 2014 | 2014-06-30 | −3,748.70% | −3536.62 pp |
| Q1 2014 · Mar 31 | 2014-03-31 | −373.48% | −50.07 pp |
| Q1 2014 · Sep 30 | 2013-09-30 | −250.32% | +394.28 pp |
| Q4 2013 | 2013-06-30 | −281.00% | +151.15 pp |
| Q3 2013 | 2013-03-31 | −212.09% | +62.61 pp |
| Q2 2013 | 2012-12-31 | −323.41% | +314.13 pp |
| Q1 2013 | 2012-09-30 | −644.60% | −536.34 pp |
| Q4 2012 | 2012-06-30 | −432.15% | −223.31 pp |
| Q1 2012 | 2012-03-31 | −274.69% | −205.30 pp |
| Q4 2011 | 2011-12-31 | −637.54% | −578.91 pp |
| Q3 2011 | 2011-09-30 | −108.26% | −32.38 pp |
| Q2 2011 | 2011-06-30 | −208.85% | — |
| Q1 2011 | 2011-03-31 | −69.40% | — |
| Q3 2010 | 2010-09-30 | −58.63% | — |
| Q2 2010 | 2010-06-30 | −75.88% | — |
Over the last five reported fiscal years, InspireMD's operating margin decreased from −417.71% to −552.56%, a change of −134.85 percentage points. The latest reported quarter, Q2 2026, shows −815.64%.
Operating margin measures the percentage of revenue left after operating costs and expenses. It shows how much operating profit a company generates from each dollar of revenue.
TickerStat calculates operating margin as SEC-reported operating income divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review InspireMD filings at SEC.gov ↗